Molecular imaging methods are rapidly evolving. Hybrid systems allow correlating function and morphology with unprecedented accuracy and resolution. The PMOD software has been designed for researchers in this challenging field. It provides solutions for all stages of quantitative data processing, helping the researchers focus on contents rather than tool programming.
PMOD consists of a comprehensive set of user-friendly and powerful tools, each corresponding to a major task such as kinetic modeling, parametric mapping, image registration, 3D rendering and pattern analysis. Due to their smooth interaction, they form a flexible workbench for all kinds of research data from humans and other species.
To date, the user community includes more than 550 sites with over 1000 users worldwide. Most of them are dedicated to PET or SPECT research. Others take advantage of the unique image analysis capabilities for solving difficult questions in their routine work. The application of PMOD for research is documented in over 1300 peer-reviewed publications.
PMOD is a Java application and is currently offered under Windows, Linux and MacOSX. It runs on standard 64-Bit computer platforms. At least 16 GB RAM, a multi-core processor, and a dedicated mid- to high-end graphics card are recommended for comfortably working with experimental data.
PMOD is compatible with the image data from all major clinical and preclinical system vendors. Images can be read and written in DICOM as well as in multiple native formats. Therefore, PMOD is immediately productive in virtually all environments without additional efforts or investments.
Online Demo starts PMOD directly from Java enabled Internet Browser.
PMOD Online should be used with 64-bit Internet Browser.
Windows: Internet Explorer 11 can be used together with Oracle Java 8 64-bit
MacOS X, Linux: 64-bit Firefox browser is available at https://www.mozilla.org/en-US/firefox/channel/#firefox
PMOD Online requires Oracle Java 8. Java is available at http://www.java.com
Note: PMOD Tools have no approval for clinical use.